Article Text
Articles
▼Olanzapine, ▼sertindole and schizophrenia
Relevant BNF section: 4.2.1
Abstract
Two 'atypical' antipsychotic drugs, olanzapine (Zyprexa - Lilly) and sertindole (Serdolect - Lundbeck), were introduced in late 1996. Both drugs are licensed for the treatment of patients with schizophrenia, which affects nearly 1% of people within their lifetime.1 Here we discuss whether olanzapine and sertindole have any advantages over conventional antipsychotic drugs2 or the other, older, 'atypical' antipsychotics, risperidone3 and clozapine.4
Statistics from Altmetric.com
Relevant BNF section: 4.2.1